Bank of America’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.89M | Buy |
2,199,059
+397,905
| +22% | +$1.07M | ﹤0.01% | 3171 |
|
|
2025
Q1 | $2.54M | Buy |
1,801,154
+509,910
| +39% | +$719K | ﹤0.01% | 3744 |
|
|
2024
Q4 | $2.57M | Sell |
1,291,244
-1,206,696
| -48% | -$2.4M | ﹤0.01% | 3570 |
|
|
2024
Q3 | $7.87M | Buy |
2,497,940
+1,281,522
| +105% | +$4.04M | ﹤0.01% | 2812 |
|
|
2024
Q2 | $3.84M | Buy |
1,216,418
+22,571
| +2% | +$71.3K | ﹤0.01% | 3287 |
|
|
2024
Q1 | $5.36M | Sell |
1,193,847
-331,894
| -22% | -$1.49M | ﹤0.01% | 3006 |
|
|
2023
Q4 | $2.53M | Sell |
1,525,741
-8,190
| -0.5% | -$13.6K | ﹤0.01% | 3453 |
|
|
2023
Q3 | $1.38M | Sell |
1,533,931
-132,781
| -8% | -$119K | ﹤0.01% | 3811 |
|
|
2023
Q2 | $3.58M | Buy |
1,666,712
+21,904
| +1% | +$47.1K | ﹤0.01% | 3121 |
|
|
2023
Q1 | $3.21M | Buy |
1,644,808
+40,182
| +3% | +$78.4K | ﹤0.01% | 3368 |
|
|
2022
Q4 | $6.16M | Buy |
1,604,626
+1,597,765
| +23,288% | +$6.14M | ﹤0.01% | 2727 |
|
|
2022
Q3 | $33K | Buy |
6,861
+519
| +8% | +$2.5K | ﹤0.01% | 5978 |
|
|
2022
Q2 | $50K | Sell |
6,342
-1,267
| -17% | -$9.99K | ﹤0.01% | 6027 |
|
|
2022
Q1 | $112K | Sell |
7,609
-93,268
| -92% | -$1.37M | ﹤0.01% | 6017 |
|
|
2021
Q4 | $2.04M | Buy |
100,877
+92,621
| +1,122% | +$1.87M | ﹤0.01% | 3884 |
|
|
2021
Q3 | $225K | Sell |
8,256
-1,630
| -16% | -$44.4K | ﹤0.01% | 5385 |
|
|
2021
Q2 | $240K | Sell |
9,886
-3,993
| -29% | -$96.9K | ﹤0.01% | 5214 |
|
|
2021
Q1 | $339K | Buy |
13,879
+11,462
| +474% | +$280K | ﹤0.01% | 5028 |
|
|
2020
Q4 | $77K | Sell |
2,417
-1,500
| -38% | -$47.8K | ﹤0.01% | 5370 |
|
|
2020
Q3 | $129K | Buy |
3,917
+407
| +12% | +$13.4K | ﹤0.01% | 4928 |
|
|
2020
Q2 | $164K | Buy |
+3,510
| New | +$164K | ﹤0.01% | 4826 |
|